Literature DB >> 11161117

Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: a controlled study on prevalence and characteristics.

B Van Houdenhove1, E Neerinckx, R Lysens, H Vertommen, L Van Houdenhove, P Onghena, R Westhovens, M B D'Hooghe.   

Abstract

The authors studied the prevalence and characteristics of different forms of victimization in 95 patients suffering from chronic fatigue syndrome (CFS) or fibromyalgia (FM) compared with a chronic disease group, including rheumatoid arthritis (RA) and multiple sclerosis (MS) patients, and a matched healthy control group. The authors assessed prevalence rates, nature of victimization (emotional, physical, sexual), life period of occurrence, emotional impact, and relationship with the perpetrator by a self-report questionnaire on burdening experiences. CFS and FM patients showed significantly higher prevalences of emotional neglect and abuse and of physical abuse, with a considerable subgroup experiencing lifelong victimization. The family of origin and the partner were the most frequent perpetrators. With the exception of sexual abuse, victimization was more severely experienced by the CFS/FM group. No differences were found between healthy control subjects or RA/MS patients, and between CFS and FM patients. These findings support etiological hypotheses suggesting a pivotal role for chronic stress in CFS and FM and may have important therapeutic implications.

Entities:  

Mesh:

Year:  2001        PMID: 11161117     DOI: 10.1176/appi.psy.42.1.21

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  29 in total

Review 1.  The long-term health outcomes of childhood abuse. An overview and a call to action.

Authors:  Kristen W Springer; Jennifer Sheridan; Daphne Kuo; Molly Carnes
Journal:  J Gen Intern Med       Date:  2003-10       Impact factor: 5.128

Review 2.  Is childhood abuse a risk factor for chronic pain in adulthood?

Authors:  Karen G Raphael; Helena K Chandler; Donald S Ciccone
Journal:  Curr Pain Headache Rep       Date:  2004-04

3.  Persistent pain: the need for a cooperative approach.

Authors:  Christopher Dowrick
Journal:  Br J Gen Pract       Date:  2011-10       Impact factor: 5.386

4.  The health effects of at-home written emotional disclosure in fibromyalgia: a randomized trial.

Authors:  Mazy E Gillis; Mark A Lumley; Angelia Mosley-Williams; James C C Leisen; Timothy Roehrs
Journal:  Ann Behav Med       Date:  2006-10

5.  Reproducibility and validity of heart rate variability and respiration rate measurements in participants with prolonged fatigue complaints.

Authors:  Judith K Sluiter; Alida M Guijt; Monique H Frings-Dresen
Journal:  Int Arch Occup Environ Health       Date:  2008-11-26       Impact factor: 3.015

6.  Association of abuse history with symptom severity and quality of life in patients with fibromyalgia.

Authors:  Juan Jiao; Ann Vincent; Stephen S Cha; Connie A Luedtke; Terry H Oh
Journal:  Rheumatol Int       Date:  2014-08-18       Impact factor: 2.631

7.  Contributions of physical and sexual abuse to women's experiences with chronic pelvic pain.

Authors:  Ellen L Poleshuck; Robert H Dworkin; Fred M Howard; David C Foster; Cleveland G Shields; Donna E Giles; Xin Tu
Journal:  J Reprod Med       Date:  2005-02       Impact factor: 0.142

8.  The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample.

Authors:  Randy Neblett; Howard Cohen; YunHee Choi; Meredith M Hartzell; Mark Williams; Tom G Mayer; Robert J Gatchel
Journal:  J Pain       Date:  2013-03-13       Impact factor: 5.820

9.  Risk factors for fibromyalgia: the role of violence against women.

Authors:  Isabel Ruiz-Pérez; Juncal Plazaola-Castaño; Rafael Cáliz-Cáliz; Isabel Rodríguez-Calvo; Antonio García-Sánchez; Miguel Angel Ferrer-González; Manuel Guzmán-Ubeda; María del Río-Lozano; Isabel López-Chicheri García
Journal:  Clin Rheumatol       Date:  2009-03-10       Impact factor: 2.980

10.  Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction.

Authors:  Amos Ben-Zvi; Suzanne D Vernon; Gordon Broderick
Journal:  PLoS Comput Biol       Date:  2009-01-23       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.